Cheviot Value Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.6M Buy
171,470
+1,734
+1% +$200K 2.07% 15
2025
Q4
$18.1M Buy
169,736
+4,424
+3% +$415K 1.78% 16
2025
Q3
$14.4M Buy
165,312
+7,027
+4% +$579K 1.53% 19
2025
Q2
$12.8M Buy
158,285
+12,704
+9% +$1.01M 1.46% 21
2025
Q1
$12.1M Buy
145,581
+26,575
+22% +$2.48M 1.48% 22
2024
Q4
$11.8M Buy
119,006
+10,750
+10% +$1.11M 2.26% 13
2024
Q3
$12.3M Sell
108,256
-5,185
-5% -$616K 2.32% 13
2024
Q2
$14M Sell
113,441
-1,666
-1% -$215K 2.74% 12
2024
Q1
$15.2M Sell
115,107
-642
-0.6% -$79.1K 3.33% 10
2023
Q4
$12.7M Sell
115,749
-2,427
-2% -$252K 2.74% 13
2023
Q3
$12.2M Sell
118,176
-40
-0% -$4.31K 2.69% 15
2023
Q2
$13.6M Buy
118,216
+2,166
+2% +$246K 2.97% 12
2023
Q1
$12.3M Sell
116,050
-987
-0.8% -$107K 2.97% 13
2022
Q4
$13.1M Sell
117,037
-2,681
-2% -$274K 3.22% 13
2022
Q3
$10.3M Sell
119,718
-1,832
-2% -$164K 2.82% 15
2022
Q2
$11.1M Sell
121,550
-1,782
-1% -$158K 2.76% 16
2022
Q1
$10.1M Buy
123,332
+16,322
+15% +$1.29M 2.14% 18
2021
Q4
$8.2M Buy
107,010
+2,446
+2% +$195K 1.92% 18
2021
Q3
$7.85M Buy
104,564
+11,296
+12% +$859K 2.01% 17
2021
Q2
$7.25M Buy
93,268
+47,296
+103% +$3.52M 1.78% 20
2021
Q1
$3.38M Buy
45,972
+8,946
+24% +$660K 0.94% 30
2020
Q4
$2.89M Buy
37,026
+1,413
+4% +$108K 0.87% 32
2020
Q3
$2.82M Buy
35,613
+948
+3% +$74.3K 0.98% 27
2020
Q2
$2.56M Sell
34,665
-124
-0.4% -$9.34K 1% 27
2020
Q1
$2.55M Sell
34,789
-1,012
-3% -$79.5K 1.16% 24
2019
Q4
$3.11M Sell
35,801
-291
-0.8% -$23.9K 1.2% 25
2019
Q3
$2.9M Sell
36,092
-232
-0.6% -$18.6K 1.24% 25
2019
Q2
$2.91M Sell
36,324
-140
-0.4% -$10.7K 1.26% 25
2019
Q1
$2.89M Sell
36,464
-158
-0.4% -$11.8K 1.41% 25
2018
Q4
$2.67M Sell
36,622
-11,482
-24% -$811K 1.39% 23
2018
Q3
$3.26M Sell
48,104
-1,394
-3% -$88.8K 1.53% 22
2018
Q2
$2.87M Sell
49,498
-4,727
-9% -$267K 1.41% 22
2018
Q1
$2.82M Sell
54,225
-983
-2% -$53.1K 1.47% 20
2017
Q4
$2.96M Sell
55,208
-1,749
-3% -$97K 1.54% 20
2017
Q3
$3.48M Sell
56,957
-275
-0.5% -$16.7K 1.89% 19
2017
Q2
$3.5M Sell
57,232
-2,477
-4% -$151K 2.04% 19
2017
Q1
$3.62M Sell
59,709
-1,109
-2% -$67.3K 2.04% 20
2016
Q4
$3.42M Buy
60,818
+7,724
+15% +$452K 2.05% 19
2016
Q3
$3.16M Sell
53,094
-36,683
-41% -$2.15M 1.96% 20
2016
Q2
$4.93M Sell
89,777
-699
-0.8% -$37.2K 2.95% 10
2016
Q1
$4.57M Sell
90,476
-3,050
-3% -$149K 2.92% 11
2015
Q4
$4.71M Sell
93,526
-1,055
-1% -$53.2K 3.05% 11
2015
Q3
$4.46M Sell
94,581
-1,587
-2% -$84.3K 2.96% 12
2015
Q2
$5.22M Sell
96,168
-1,017
-1% -$57K 3.09% 12
2015
Q1
$5.33M Sell
97,185
-217
-0.2% -$12.3K 3.14% 12
2014
Q4
$5.28M Sell
97,402
-705
-0.7% -$39.3K 3.07% 12
2014
Q3
$5.55M Sell
98,107
-2,208
-2% -$124K 3.22% 11
2014
Q2
$5.54M Sell
100,315
-1,114
-1% -$60.8K 2.96% 12
2014
Q1
$5.49M Sell
101,429
-5,415
-5% -$280K 3.03% 12
2013
Q4
$5.1M Sell
106,844
-1,152
-1% -$52.7K 2.82% 14
2013
Q3
$4.91M Sell
107,996
-1,538
-1% -$70.2K 2.71% 13
2013
Q2
$4.86M Buy
+109,534
New +$4.89M 2.65% 12

Other funds holding MRK

Cheviot Value Management's MRK Position: Q1 2026 in Review

Cheviot Value Management increased its Merck (MRK) stake by 1% in Q1 2026, buying an estimated $200K and bringing the position to 171,470 shares worth $20.6M. The position accounts for 2.07% of the portfolio, ranked #15.

Cheviot Value Management first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Cheviot Value Management held 171,470 shares of Merck worth $20.6M as of Q1 2026.
  • Cheviot Value Management bought 1,734 Merck shares in Q1 2026, an estimated $200K.
  • Merck made up 2.07% of Cheviot Value Management's portfolio in Q1 2026, its #15 holding.
  • Cheviot Value Management first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Cheviot Value Management's 13F filing for Q1 2026, filed 12 May 2026.